Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fluor (FLR) Common Equity (2016 - 2026)

Fluor has reported Common Equity over the past 17 years, most recently at $3.3 billion for Q4 2025.

  • Quarterly Common Equity fell 17.91% to $3.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 billion through Dec 2025, down 17.91% year-over-year, with the annual reading at $3.3 billion for FY2025, 17.91% down from the prior year.
  • Common Equity was $3.3 billion for Q4 2025 at Fluor, down from $5.2 billion in the prior quarter.
  • Over five years, Common Equity peaked at $6.0 billion in Q2 2025 and troughed at $1.2 billion in Q1 2021.
  • The 5-year median for Common Equity is $2.0 billion (2022), against an average of $2.5 billion.
  • The largest YoY upside for Common Equity was 166.52% in 2025 against a maximum downside of 17.91% in 2025.
  • A 5-year view of Common Equity shows it stood at $1.6 billion in 2021, then grew by 27.38% to $2.0 billion in 2022, then grew by 2.81% to $2.1 billion in 2023, then soared by 94.54% to $4.0 billion in 2024, then dropped by 17.91% to $3.3 billion in 2025.
  • Per Business Quant, the three most recent readings for FLR's Common Equity are $3.3 billion (Q4 2025), $5.2 billion (Q3 2025), and $6.0 billion (Q2 2025).